← Back to Search

Diagnostic Test

MRI for Prostate Cancer

N/A
Recruiting
Led By Clare Tempany-Afdhal
Research Sponsored by ECOG-ACRIN Cancer Research Group
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Recently diagnosed with prostate cancer for whom definitive surgical treatment is indicated
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 years
Awards & highlights

Study Summary

This trial looks at how well MRI works in finding and staging prostate cancer, which may help treatment planning.

Who is the study for?
This trial is for men recently diagnosed with prostate cancer who are candidates for definitive surgery. It's not open to those who've had previous treatments for prostate cancer, major pelvic surgeries like hip replacements, or can't have an MRI due to severe claustrophobia, certain metal implants, kidney failure, or exceeding the scanner's weight limit.Check my eligibility
What is being tested?
The study is testing how well a type of advanced imaging called multiparametric MRI works in assessing the stage of prostate cancer and aiding in treatment planning. The goal is to see if this MRI technique can better identify aggressive types of prostate cancer.See study design
What are the potential side effects?
Potential side effects mainly relate to undergoing an MRI scan and may include discomfort from lying still during the procedure, loud noises from the machine (ear protection is provided), and reactions to contrast agents used such as nausea or allergic reactions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have recently been diagnosed with prostate cancer and need surgery.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Diagnostic performance of overall prostate imaging reporting and data system (PI-RADS) score
Risk prediction model
Secondary outcome measures
Diagnostic performance of the individual prostate imaging reporting and data system (PI-RADS) score

Trial Design

1Treatment groups
Experimental Treatment
Group I: Diagnostic (mpMRI)Experimental Treatment1 Intervention
Patients undergo mpMRI within 3 months prior to schedule surgery.

Find a Location

Who is running the clinical trial?

ECOG-ACRIN Cancer Research GroupLead Sponsor
116 Previous Clinical Trials
176,070 Total Patients Enrolled
4 Trials studying Prostate Cancer
1,070 Patients Enrolled for Prostate Cancer
National Cancer Institute (NCI)NIH
13,664 Previous Clinical Trials
40,925,154 Total Patients Enrolled
560 Trials studying Prostate Cancer
506,243 Patients Enrolled for Prostate Cancer
Clare Tempany-AfdhalPrincipal InvestigatorECOG-ACRIN Cancer Research Group

Media Library

Multiparametric Magnetic Resonance Imaging (Diagnostic Test) Clinical Trial Eligibility Overview. Trial Name: NCT03697148 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment currently available for this clinical experiment?

"Per the data available on clinicaltrials.gov, enrollment is ongoing for this medical trial that was initially posted in July of 2018 and last updated at the end of June 2022."

Answered by AI

How many research participants are currently included in this experiment?

"To complete this trial, 852 participants that meet the enumerated criteria need to be recruited. There are two primary sites offering participation in this study: Mayo Clinic Hospital located in Phoenix, Arizona and another location at the original Mayo Clinic facility in Rochester, Minnesota."

Answered by AI

Is there a substantial presence of this research taking place in North America?

"This trial has 43 active sites, such as Mayo Clinic Hospital in Phoenix, Mayo Clinic Rochester and Mayo Clinic Arizona Scottsdale."

Answered by AI

Who else is applying?

What state do they live in?
New York
What site did they apply to?
Stony Brook University Medical Center
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

Looking to make extra money.
PatientReceived 2+ prior treatments
Recent research and studies
clinicaltrials.govStudy
Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer
2019. "Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03697148.
All > Hawaii
~97 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top